:format(webp)/cdn.mskdoctors.com/storage/2026/8/o4Unkdhfd70nkKq7mxPVy7ZOCcjGpLrE.jpg)
What 'medically cleared' means after ACL reconstructionClearance after ACL reconstruction requires simultaneous passage of three criteria: strength and hop-test symmetry of 90–95% compared to the uninjured leg, plus a psychological readiness score of 80 or above. The nine-month post-operative minimum exists because earlier return raises reinjury risk sevenfold.Clearance after ACL reconstruction requires simultaneous passage of three criteria: strength and hop-test symmetry of 90–95% compared to the uninjured leg, plus a psychological readiness score of 80 or above. The nine-month post-operative minimum exists because earlier return raises reinjury risk sevenfold.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/WyTUgPyuRTUUHCpsWkxQLHIH1zV03yj2.jpg)
Can ChondroFiller delay joint replacement?An injectable collagen scaffold called ChondroFiller recruits the patient's own repair cells to regenerate cartilage in 30–45 minutes. Clinical trials show IKDC score improvements averaging 32.4 points — nearly double the threshold for clinically significant change — when administered in early focal cartilage damage where joint space remains.An injectable collagen scaffold called ChondroFiller recruits the patient's own repair cells to regenerate cartilage in 30–45 minutes. Clinical trials show IKDC score improvements averaging 32.4 points — nearly double the threshold for clinically significant change — when administered in early focal cartilage damage where joint space remains.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/2of3MbpwJvcJrDYn03x9VVz3ZGqDUeFf.jpg)
ChondroFiller vs hyaluronic acid for cartilage repairChondroFiller repairs focal cartilage lesions by recruiting the patient's own cells; hyaluronic acid eases broad osteoarthritis by restoring synovial fluid. These injections treat fundamentally different conditions, and selecting the wrong one offers little clinical value.ChondroFiller repairs focal cartilage lesions by recruiting the patient's own cells; hyaluronic acid eases broad osteoarthritis by restoring synovial fluid. These injections treat fundamentally different conditions, and selecting the wrong one offers little clinical value.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/LVSf9I2NvzygDmuXmXGTWU6KzE0VtMfx.jpg)
Grade 1 hamstring strain recovery and return to sportGrade 1 hamstring strains typically resolve in one to four weeks, but pain disappears before strength symmetry and neuromuscular control are fully restored, making premature return the primary driver of the 15–16% reinjury rate.Grade 1 hamstring strains typically resolve in one to four weeks, but pain disappears before strength symmetry and neuromuscular control are fully restored, making premature return the primary driver of the 15–16% reinjury rate.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/766rT75vrzgAcHwc9vxAXYr5JrU3PaGe.jpg)
ChondroFiller injection versus knee replacement for focal defectsChondroFiller, a gelling collagen scaffold that recruits the patient's own cells to repair cartilage, suits isolated focal defects; knee replacement addresses widespread multi-compartment osteoarthritis.ChondroFiller, a gelling collagen scaffold that recruits the patient's own cells to repair cartilage, suits isolated focal defects; knee replacement addresses widespread multi-compartment osteoarthritis.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/0Nsk0m16zbtsTTRmthFyMnqy1JLNLGzj.jpg)
When Are You Ready to Play After ACL Surgery?Time-based clearance after ACL reconstruction surgery fails to identify readiness: only 65% of athletes regain their pre-injury level, and young athletes face 23–29% risk of second injury. Multi-criterion assessment across strength symmetry, movement quality, neuromuscular control, and psychological readiness better predicts true readiness.Time-based clearance after ACL reconstruction surgery fails to identify readiness: only 65% of athletes regain their pre-injury level, and young athletes face 23–29% risk of second injury. Multi-criterion assessment across strength symmetry, movement quality, neuromuscular control, and psychological readiness better predicts true readiness.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/8ilKw2XCH5pB5TWOt6kewJNVnwz4zE0V.jpg)
What the ChondroFiller evidence actually showsChondroFiller's reoperation rate of 3–8% substantially outperforms microfracture (41%) and ACI/MACI (37%), reflecting its mechanism: the scaffold supports hyaline-like cartilage repair rather than the fibrocartilage scar tissue that other approaches produce.ChondroFiller's reoperation rate of 3–8% substantially outperforms microfracture (41%) and ACI/MACI (37%), reflecting its mechanism: the scaffold supports hyaline-like cartilage repair rather than the fibrocartilage scar tissue that other approaches produce.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/ETKg1ueF5BBKIau7DxGIoPsVzI5r2krh.jpg)
ChondroFiller and Arthrosamid serve different knee conditionsChondroFiller recruits progenitor cells to rebuild focal cartilage defects, whilst Arthrosamid provides permanent cushioning for diffuse osteoarthritis by integrating into the joint capsule; the choice between them follows from what MRI reveals about the damage pattern, not from symptom severity.ChondroFiller recruits progenitor cells to rebuild focal cartilage defects, whilst Arthrosamid provides permanent cushioning for diffuse osteoarthritis by integrating into the joint capsule; the choice between them follows from what MRI reveals about the damage pattern, not from symptom severity.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/UY0InSBaoOinSJHR9T3qmZrV7DMIQOXA.jpg)
ChondroFiller vs PRP for focal cartilage defectsFocal cartilage defects and diffuse cartilage loss are different problems requiring different solutions. ChondroFiller, a collagen scaffold, physically occupies and stabilises focal voids, recruiting repair cells over 12–24 months. PRP releases growth factors to reduce inflammation but cannot fill a structural gap. Imaging reveals which mechanism addresses the patient's underlying…Focal cartilage defects and diffuse cartilage loss are different problems requiring different solutions. ChondroFiller, a collagen scaffold, physically occupies and stabilises focal voids, recruiting repair cells over 12–24 months. PRP releases growth factors to reduce inflammation but cannot fill a structural gap. Imaging reveals which mechanism addresses the patient's underlying problem.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/nJpuPYmYxVIJuCuke5TmcJtXlcYJxImS.jpg)
ChondroFiller or Arthrosamid for your kneeChondroFiller repairs focal cartilage defects via a collagen scaffold, and Arthrosamid provides cushioning by integrating into the synovial lining — because they target different anatomical structures, the MRI scan, not patient preference, determines which injection is appropriate.ChondroFiller repairs focal cartilage defects via a collagen scaffold, and Arthrosamid provides cushioning by integrating into the synovial lining — because they target different anatomical structures, the MRI scan, not patient preference, determines which injection is appropriate.
:format(webp)/cdn.mskdoctors.com/storage/2026/6/Ftb0eLP1qk86rzkUGQIcwelqCKAR75gI.jpg)
ChondroFiller injection vs PRP for cartilage repairChondroFiller fills focal cartilage defects with a collagen scaffold; PRP modulates inflammation in diffuse wear. MRI findings, not symptoms, determine which applies.ChondroFiller fills focal cartilage defects with a collagen scaffold; PRP modulates inflammation in diffuse wear. MRI findings, not symptoms, determine which applies.
:format(webp)/cdn.mskdoctors.com/storage/2026/5/ZblwdFdi3Q4Yy8tyYSJSAsJS9CBjfOtg.jpg)
Choosing Arthrosamid knee injections for osteoarthritisArthrosamid is a single ultrasound-guided hydrogel injection for mild-to-moderate knee osteoarthritis, used when exercise, painkillers and other non-surgical care have not eased function-limiting pain. Early studies show meaningful improvement for many patients at 12 months, but evidence remains less robust than for established treatments.Arthrosamid is a single ultrasound-guided hydrogel injection for mild-to-moderate knee osteoarthritis, used when exercise, painkillers and other non-surgical care have not eased function-limiting pain. Early studies show meaningful improvement for many patients at 12 months, but evidence remains less robust than for established treatments.
